Professor Robert Marks of Ben-Gurion University Confirms Participation in MTWF 2018 Medical Technology World Forum

Hosted by VCBeat, Eggshell Research Institute, and the Industry-University-Research Cooperation Coordination Department of the China High-Tech Industrialization Research Association“Infinity” – The 2018 World Forum on Medical Technology will be held at the Le Méridien Shanghai, Minhang Baolong Hotel on September 26–27.

Robert Marks, a full-time professor at Ben-Gurion University of the Negev in Israel, has confirmed his attendance at “Infinity” – the 2018 World Forum on Medical Technology.

[Profile]

Professor Robert Marks is a full-time professor at Ben-Gurion University of the Negev in Israel. For the past 25 years, his research has primarily focused on medical biosensors, clinical diagnostics, and environmental toxicity monitoring. He has authored over 155 publications and holds multiple patents. Professor Marks is the inventor and co-founder of two diagnostic startups: Biosensorix (based in Singapore) and EclipseDx (based in the United States). His anti-biofilm technology has been licensed to LifeMatters (an Israeli company).

On September 26, Robert Marks, a full-time professor at Ben-Gurion University of the Negev in Israel, will attend the “Infinity” – 2018 World Forum on Medical Technology, co-hosted by VCBeat, VBInsight, and the Industry-Academia-Research Cooperation Coordination Department of the China High-Tech Industrialization Research Association.

Scan the QR code to register. Early bird tickets are on sale for a limited time...

[Conference Details]

We can now see that digital technologies such as artificial intelligence, robotics, 3D printing, and the Internet of Things are impacting various industries, with continuous technological innovation disrupting the healthcare sector.

With the introduction of the “Development Plan for New Generation Artificial Intelligence” and the “Opinions on Promoting the Development of ‘Internet + Healthcare’,” capital has flooded into the sector, giving rise to numerous high-valued AI startups, while commercialization pathways continue to be explored.

The “Healthy China 2030” Planning Outline was released, and three major health and medical data groups were established. The explosive growth in data, driven by declining costs of data acquisition from gene sequencing and wearable devices, has laid the scale foundation for big data and AI analysis.

With the growing acceptance of robotic applications in China’s healthcare sector and their widespread adoption across various stages of diagnosis and treatment, medical robots—particularly surgical robots—have become “high-demand products” within the robotics industry. Robots are increasingly being deployed in hospitals, with domestic technologies steadily catching up to international advancements.

Medical 3D printing has entered a transition period from the primary to the intermediate stage. Dental prosthetics and customized prostheses have already achieved commercialization and are developing rapidly. Orthopedics has become a key focus of market competition, attracting various enterprises to establish their presence. New breakthroughs have been made in organ and tissue trials, making clinical applications in humans promising.

In April this year, the National Health Commission released the "Standards and Specifications for Hospital Information Construction in China (Trial)," which clearly defined 21 application scenarios for IoT-based positioning and data monitoring. With the introduction of these standards, the direction of the IoT industry has become increasingly clear, and scenario-based applications are beginning to stand out;

In the genomics sector, tumor detection is poised for rapid growth, microbiomics is gradually maturing under policy guidance, and consumer genetic testing has entered the “20-yuan” era.

Technological innovation enterprises have begun to explore their own paths for application implementation, scaling from 1 to N...

2018 World Medical Technology Forum, themed “Infinity”to be held onSeptember 26–27, 2018InHosted by Le Méridien Shanghai, Minhang Baolong。

This forum will bring together domestic and international healthcare service providers, listed companies, financial institutions, and health-tech innovators centered on technological innovation. It will explore five key dimensions—policy, capital, data, technology, and commercialization pathways—focusing on the commercial applications of five major technologies (AI, big data, robotics, 3D printing, and IoT, along with genetic testing) within hospitals, pharmaceutical companies, and third-party healthcare service providers. The event will feature eight core forums, address over 80 hot topics, and gather more than 80 industry leaders, 100+ investors, 300+ entrepreneurs, and 30+ media outlets in Shanghai to spark intellectual exchange and foster collaboration.

If you are a government official, healthcare practitioner, or industry professional focused on technological innovation in health and medicine—including executives from medical informatics companies, medical device manufacturers, pharmaceutical firms, and insurance companies; industry investors; healthcare media professionals; and leaders of public or startup companies engaged in big data and AI-powered healthcare—this industry forum is tailored specifically for you.

You Are Only One Ticket Away from Industry Leaders

Scan the QR code to register. Limited-time early bird tickets are now available...